In contrast, in our study on naringenin's antifibrotic effects in oral submucous fibrosis (OSMF) focuses on molecular targets such as MMP2, MMP3, MMP9, TGFB1, ESR1, and SERPINE1, which are crucial in ECM remodeling and inflammation. This evidence concerns the gene MMP2 and oral submucous fibrosis.